Aspirin Resistance: Clinical and Molecular Genetic Evaluation Techniques


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The article discusses the issues related to the personalization of preventive measures for ischemic stroke, in particular those associated with resistance to one of the most common antiplatelet drugs, aspirin. A brief historical note on investigation of acetylsalicylic acid is provided. The paper addresses the issue of etiological factors and epidemiology of aspirin resistance. An analysis and comparison of various techniques for evaluation of this phenomenon are performed. Separately, a molecular genetic aspect of the pathology is considered. In conclusion, the recommendations for overcoming tolerance to aspirin therapy are provided.

Авторлар туралы

M. Tanashyan

Research Center of Neurology

Email: rasckey@live.com
Ресей, Moscow

M. Domashenko

Research Center of Neurology

Email: rasckey@live.com
Ресей, Moscow

A. Raskurazhev

Research Center of Neurology

Хат алмасуға жауапты Автор.
Email: rasckey@live.com
Ресей, Moscow

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Inc., 2017